Clinical Trials Directory

Trials / Completed

CompletedNCT02862886

Study of the Effect of Beta-3 Adrenergic Receptor Agonists on Oxidative Stress and Signalling Pathways Implicated in Remodelling of the Uteroplacental Space: Experimental in Vitro Approach on Myometrial Tissue Explants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

CHRONOLOGICAL DESCRIPTION OF THE STUDY 1. Information provided to study participants 2. Collection of written informed consent 3. Harvesting of myometrial biopsies 4. Creation of tissue explants using myometrial biopsies 5. Stimulation of the explants with LPS 6. Study of the effect of SAR150640 (beta3-adrenergic agonist) on LPS-induced oxidative stress Moreover, demonstrating the ability of beta3-adrenergic receptor agonists to prevent the appearance of oxidative stress and its consequences on tissues, as a complement to previous studies, is an additional argument for the clinical development of this class of pharmaceuticals in the management of threatened premature delivery and labour induction.

Conditions

Interventions

TypeNameDescription
OTHERmyometrium biopsy

Timeline

Start date
2010-07-01
Primary completion
2013-01-01
First posted
2016-08-11
Last updated
2016-08-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02862886. Inclusion in this directory is not an endorsement.

Study of the Effect of Beta-3 Adrenergic Receptor Agonists on Oxidative Stress and Signalling Pathways Implicated in Rem (NCT02862886) · Clinical Trials Directory